BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Apotex Strengthens Osteoporosis Care in Canada with Health Canada’s Approval of DENOZA™, a Denosumab Biosimilar

  April 7, 2026

   · 

  2 min read
• 

  Mergers & acquisitions

  Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis

  The acquisition of Tubulis GmbH—Gilead Sciences’ latest of the year after buying Arcellx and Ouro Medicines—brings into the fold a novel ovarian cancer candidate that has demonstrated promising mid-stage data.

  April 7, 2026

   · 

  2 min read

   · 

  Heather McKenzie
• Press Releases

  Welo Life Sciences Launches as Dedicated Brand for Pharmaceutical, Contract Research, and Medical Device Organizations

  April 7, 2026

   · 

  1 min read
• Press Releases

  TempraMed Announces Additional Granted Brazilian Patent for Newest VIVI Box Product

  April 7, 2026

   · 

  1 min read
• Press Releases

  BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon(R) Platform

  April 7, 2026

   · 

  1 min read
• Press Releases

  Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors

  April 7, 2026

   · 

  1 min read
• Press Releases

  Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference

  April 7, 2026

   · 

  1 min read
• Press Releases

  Rosalind Franklin University Incubator Company Presents Promising Glioblastoma Therapy Data at Major Brain Cancer Conference

  April 7, 2026

   · 

  1 min read